Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Involvement of YTHDF1 in renal fibrosis progression via up‐regulating YAP
Jia Xing, Yuchen He, Kaiyue Wang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 2
Closed Access | Times Cited: 24

Showing 24 citing articles:

METTL3 Potentiates M2 Macrophage‐Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF‐β1/Smad3 Pathway
Qinfan Yao, Xiaoxiao Zheng, Xinyi Zhang, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
METTL3 promotes renal ischemia‐reperfusion injury by modulating miR‐374b‐5p/SRSF7 axis
Kun Zhu, Shirui Sun, Zepeng Li, et al.
The FASEB Journal (2025) Vol. 39, Iss. 3
Closed Access | Times Cited: 1
METTL3-mediated m6A RNA methylation induces the differentiation of lung resident mesenchymal stem cells into myofibroblasts via the miR-21/PTEN pathway
Yi Lu, Zeyu Liu, Yunjiao Zhang, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 21
YAP/TAZ: Molecular pathway and disease therapy
Yuzi Wei, Victoria Lee Zhi Hui, Yilin Chen, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 19
METTL3-mediated N6-methyladenosine modification stimulates mitochondrial damage and ferroptosis of kidney tubular epithelial cells following acute kidney injury by modulating the stabilization of MDM2-p53-LMNB1 axis
Chenghuan Hu, Buyao Zhang, Shuangping Zhao
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115677-115677
Open Access | Times Cited: 16
Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation
Lan Feng, Yang Chen, Ni Li, et al.
Life Sciences (2023) Vol. 322, pp. 121671-121671
Closed Access | Times Cited: 15
Hippo signaling in acute kidney injury to chronic kidney disease transition: Current understandings and future targets
Tahib Habshi, Vishwadeep Shelke, Ajinath Kale, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103649-103649
Closed Access | Times Cited: 11
N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs
Xiangfei Huang, Zilu Yu, Juan Tian, et al.
Briefings in Functional Genomics (2025) Vol. 24
Closed Access
Senolytic procyanidin C1 alleviates renal fibrosis by promoting apoptosis of senescent renal tubular epithelial cells
Yu Gan, Kangning Wang, Xiang Chen, et al.
The FASEB Journal (2025) Vol. 39, Iss. 2
Open Access
N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases
Junjun Luan, Jeffrey B. Kopp, Hua Zhou
Kidney International Reports (2022) Vol. 8, Iss. 1, pp. 36-50
Open Access | Times Cited: 15
Silencing of YTHDF1 Attenuates Cerebral Stroke by Inducing PTEN Degradation and Activating the PTEN/AKT/mTOR Pathway
Xiaohong Li, Peng An, Fang Han, et al.
Molecular Biotechnology (2022) Vol. 65, Iss. 5, pp. 822-832
Closed Access | Times Cited: 14
N6-methyladenosine methylation in kidney injury
Qimeng Wang, Xiaoting Fan, Qinghao Sheng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 7
RNA N6‐methyladenosine modifications and potential targeted therapeutic strategies in kidney disease
Wei‐Jian Ni, Hao Lu, Nan‐Nan Ma, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 1, pp. 5-24
Closed Access | Times Cited: 12
The Hippo pathway and its correlation with acute kidney injury
Chi Zhang, Chuanlei Li, Kexin Xu, et al.
动物学研究 (2022) Vol. 43, Iss. 5, pp. 897-910
Open Access | Times Cited: 11
Bayesian mixed model analysis uncovered 21 risk loci for chronic kidney disease in boxer dogs
Frode Lingaas, Katarina Tengvall, J. H. Jansen, et al.
PLoS Genetics (2023) Vol. 19, Iss. 1, pp. e1010599-e1010599
Open Access | Times Cited: 6
YTHDF1 mitigates acute kidney injury via safeguarding m6A-methylated mRNAs in stress granules of renal tubules
Wenwen Yang, Mingchao Zhang, Jiacheng Li, et al.
Redox Biology (2023) Vol. 67, pp. 102921-102921
Open Access | Times Cited: 3
m6A RNA methylation: The latent string-puller in fibrosis
Xinglan He, Bingsi Tang, Puyu Zou, et al.
Life Sciences (2024) Vol. 346, pp. 122644-122644
Closed Access
The Hippo-YAP1/HIF-1α pathway mediates arsenic-induced renal fibrosis
Di Wei, Yan Li, Lei Zhang, et al.
Environmental Research (2024) Vol. 257, pp. 119325-119325
Closed Access
Targeted delivery of type I TGF-β receptor-mimicking peptide to fibrotic kidney for improving kidney fibrosis therapy via enhancing the inhibition of TGF-β1/Smad and p38 MAPK pathways
Xiaohua Wang, Xiaohui Liu, Liming Xu, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112483-112483
Closed Access
Salvianolic acid B improves DEN/CCl4/C2H5OH-induced renal fibrosis by regulating YAP/TAZ and pSmad3C/pSmad3L
Lili Li, Zhenghao Shi, Yuxuan Li, et al.
Journal of Functional Foods (2024) Vol. 122, pp. 106553-106553
Open Access
m6A Ribonucleic Acid Methylation in Fibrotic Diseases of Visceral Organs
Xiaoniu Dai, Yusi Cheng, Wei Luo, et al.
Small Science (2024)
Open Access
PDGFβ receptor-targeted delivery of truncated transforming growth factor β receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-β1/Smad signaling pathway
Bing Wang, Xiaohua Wang, Yixin Dong, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 237-252
Closed Access | Times Cited: 1
Page 1

Scroll to top